On November 5 – 7, 2019, i3L hosted the first Asia Integrated Conference (AICON) in Life Science themed “Can Indonesia be a Biopharmaceutical Manufacturing Powerhouse?”. AICON in Life Sciences is a regional life science conference that aims to highlight the latest developments in the life science industry of Indonesia. In 2019, the conference highlighted the growth of the biopharmaceutical industry and aimed to accelerate and solidify the growth of the biopharmaceutical industry in Indonesia by facilitating networking and knowledge sharing among key stakeholders in the industry.
The event consisted of 3 plenary talks, 1 panel discussion on regulatory compliance, and 6 track sessions that covered different checkpoints along the supply chain of biopharmaceutical products. A total of 22 speakers and key stakeholders from the government and private sector – shared their insights on the industry. Among them were distinguished speakers including Dr. Jeremy Lim, Oliver Wyman’s Partner Health & Life Sciences Asia Pacific; Rachel Armstrong, PwC’s Senior Manager Strategy; and Prof. Helen McCarthy from the School of Pharmacy, Queen’s University Belfast. A total of 41 participants from the industry, academics, and regulatory sectors attended this important forum. This conference was made possible thanks to the 11 sponsors and exhibitors, including GE Healthcare and Life Sciences, PT. Halfmann Goetsch Partner, and Sartorius Stedim Singapore Pte Ltd.
Dr. Jeremy Lim from Oliver Wyman summed up the key message of AICON 2019: “Indonesia has many opportunities to grow to meet the local demand and to manage costs more efficiently in the biopharmaceutical manufacturing industry. However, to be a global biopharmaceutical powerhouse, radical policy and market measures will be needed to restructure the industry in Indonesia”. Therefore, the conference was simply a starting point to initiate further discussions and collaborations that will accelerate the growth of the industry. Now is the time for action!
